Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v12-EN Version v5-FR
Language English French
Date Updated 2023-02-10 2022-10-28
Drug Identification Number 02230770 02230770
Brand name METHYLENE BLUE INJECTION USP METHYLENE BLUE INJECTION USP
Common or Proper name METHYLENE BLUE INJECTION METHYLENE BLUE INJECTION
Company Name OMEGA LABORATORIES LIMITED OMEGA LABORATORIES LIMITED
Ingredients METHYLENE BLUE METHYLENE BLUE
Strength(s) 10MG 10MG
Dosage form(s) LIQUID LIQUID
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 10 x 1mL vial / fiole 10 x 1mL vial / fiole
ATC code V03AB V03AB
ATC description ALL OTHER THERAPEUTIC PRODUCTS ALL OTHER THERAPEUTIC PRODUCTS
Reason for shortage Shortage of an inactive ingredient or component. Shortage of an inactive ingredient or component.
Anticipated start date
Actual start date 2022-09-30 2022-09-30
Estimated end date 2023-02-10 2023-01-15
Actual end date 2023-02-09
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments